Security key
29842P105
EUPRAXIA PHARMACEUTICALS INC. - Common Shares, no par value (EPRX)
CUSIP: 29842P105
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Common Shares, no par value
- Total 13F shares
- 13,830,451
- Total 13F value
- $104,211,571
- Share change
- +517,128
- SEC-reported price per share
- $7.55
- Number of holders
- 35
- Value change
- +$5,872,102
- Number of buys
- 21
- Number of sells
- 10
- Shares outstanding
- 52,146,078
Holder snapshot
6 facts
Security identity
1 fact
Report period
Q4 2025
Institutions
35
Top holders
10
EPRX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2026
Previous quarter: Q3 2025
EUPRAXIA PHARMACEUTICALS INC. SEC filings
EUPRAXIA PHARMACEUTICALS INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 29842P105
Recent filing periods:
Ownership snapshot
Top reported holders of EPRX - EUPRAXIA PHARMACEUTICALS INC. - Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Beutel, Goodman & Co Ltd.
Disclosed value leader
Beutel, Goodman & Co Ltd.
Comparable rows
15/15
Latest evidence
30 Sep 2025
13D/G
13F
Lead comparable stake: 8%
13D/G row: Beutel, Goodman & Co Ltd.
Showing 1-6 of 15 holder rows.
Quick read
Beutel, Goodman & Co Ltd. leads the comparable SEC ownership view at 8%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
Beutel, Goodman & Co Ltd.
8%
Robert Disbrow
7%
BALYASNY ASSET MANAGEMENT L.P.
2.6%
Vivo Capital, LLC
2.6%
SCOTIA CAPITAL INC.
2.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Beutel, Goodman & Co Ltd. |
13D/G
13F
Company
|
8%
|
$23,947,504
4,058,899 shares
|
$0 | 30 Sep 2025 |
| Robert Disbrow |
13D/G
|
7%
|
$21,052,085
3,568,150 shares
|
$0 | 30 Sep 2025 |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
Company
|
2.6%
|
$7,965,000
1,350,000 shares
|
— | 30 Sep 2025 |
| Vivo Capital, LLC |
13F
Company
|
2.6%
|
$7,965,000
1,350,000 shares
|
— | 30 Sep 2025 |
| SCOTIA CAPITAL INC. |
13F
Company
|
2.5%
|
$7,254,710
1,277,885 shares
|
— | 30 Sep 2025 |
| GREAT POINT PARTNERS LLC |
13F
Company
|
2.3%
|
$7,080,000
1,200,000 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
35
Shares
13,830,451
Rows available
35
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
27
Q4 2025 holders
35
Holder diff
8
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend